Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one
Contents

Academy · Research Writing · Manuscript Structure Fundamentals

Research Writing: Structuring a Manuscript with IMRaD and Reporting Guidelines

The IMRaD structure (Introduction, Methods, Results and Discussion) is now embedded in reporting guidelines such as CONSORT and PRISMA because it corresponds to the way in which readers search for information in a paper, rather than because it is a stylistic convention. This article examines the function of each section and the most common structural errors.

Pubrica AcademyWritten by a scientific writing specialist Reviewed bya manuscript structure reviewer Published10 October 2026 Last checked10 October 2026 Reading time7 minutes Sources10 peer-reviewed

Research writing is the organization of the rationale, methods, findings and interpretation of a study into a sequence that a reader can follow without reading sections out of order. The dominant organizing structure, IMRaD (Introduction, Methods, Results and Discussion), is not merely a convention imposed by journals; it reflects the order in which most readers use a paper (the question asked, how it was tested, what was found and what the findings mean), and it is built directly into reporting guidelines maintained by the EQUATOR (Enhancing the QUAlity and Transparency Of health Research) Network, including CONSORT for trials and PRISMA for systematic reviews, which structure their checklists around these four sections.

Learning objectives

  • Why the IMRaD structure persists across disciplines and reporting guidelines
  • The specific function of each of the four sections, and the most common structural error in each
  • How structured reporting checklists correspond directly to manuscript sections

Common misconceptions

  • “IMRaD is merely a formatting convention that may be rearranged if the narrative reads better in another order.” Reporting guidelines maintained by the EQUATOR Network, including CONSORT and PRISMA, build their checklists around the IMRaD sections because each section has a distinct reporting function; items such as the method of randomisation belong in the Methods and items such as effect estimates belong in the Results, so that a reader seeking a particular kind of information always knows where to find it.

Persistence of the IMRaD structure across disciplines

IMRaD organizes a manuscript around the logical sequence of the study itself (why it was done, how it was done, what was found and what it means) rather than around the chronological order in which the author conducted or wrote it. This is important because readers rarely read a scientific paper from start to finish in one sitting; a clinician assessing whether the population of a trial matches their own patients will turn directly to the Methods, whereas a researcher assessing whether a finding is statistically robust will turn directly to the Results, and the stability of the structure across journals and disciplines allows both readers to find what they need without learning a new organizational scheme for every paper. The EQUATOR Network, which maintains the central library of health-research reporting guidelines, hosts CONSORT for randomized trials, PRISMA for systematic reviews and meta-analyses, and STROBE for observational studies, and all three organize their reporting checklists around the IMRaD sections, assigning specific checklist items, such as “eligibility criteria” or “outcomes”, to specific sections rather than leaving placement to the discretion of the author1.

Functions of each manuscript section

The Introduction establishes why the study was necessary: what is already known, what gap or open question remains, and what specific question or hypothesis the study addresses, building a case for relevance rather than surveying the entire field. The function of the Methods section is replicability: a reader, or another research team, should be able to reconstruct what was done (participants, interventions or exposures, outcome measures and analysis plan) in sufficient detail to assess whether the design could support the conclusions drawn. The ICMJE (International Committee of Medical Journal Editors) recommendations state explicitly that the methods section should describe how and why the study was done in a manner that allows others to replicate and evaluate it2. The Results section reports what was found without interpretation; interpretation belongs in the Discussion, which is responsible for explaining what the findings mean, how they relate to the existing literature, which limitations qualify them and what should be concluded, without introducing results not already reported in the Results section.

The abstract as a separately assessed structure

The abstract is often treated as a condensed restatement of the full manuscript, but major reporting guidelines specify a distinct, mandatory sub-structure for it rather than leaving its content to the summarizing judgment of the author. The ICMJE recommendations call for a structured abstract that mirrors IMRaD in miniature, with background, methods, results and conclusions as distinct, often explicitly labeled subsections, because readers frequently decide whether to read or cite the full paper on the basis of the abstract alone2. CONSORT extended this principle to abstracts with a dedicated checklist, the CONSORT for Abstracts extension developed by Hopewell and colleagues, which specifies that a trial abstract must report, among other items, the trial design, the result for the primary outcome with a confidence interval and the trial registration number, items that an author summarizing freely might otherwise omit for reasons of space5. The existence of a dedicated abstract-level checklist, separate from the full-paper checklist, reflects evidence discussed elsewhere in the literature on proofreading and accuracy: abstracts are read far more often than full papers and are particularly prone to inconsistency with the body text they summarize.

Extension of structure to headings and subheadings by reporting guidelines

Beyond the four main IMRaD sections, several reporting guidelines specify structure at the level of subheadings within a section, treating the placement of headings as a verifiable reporting requirement rather than a stylistic choice left to the author. The STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) Statement, developed by von Elm and colleagues, requires the Methods section to address study design, setting, participants, variables and statistical methods as separately identifiable components, and requires the Results section to address separately participant characteristics, descriptive data and the main results for each exposure-outcome relationship studied4. This level of structural specification exists because each observational design (cohort, case-control and cross-sectional) carries distinct sources of potential bias, and a reader must be able to locate the methodological detail relevant to assessing that bias, such as how exposure was measured or how controls were selected, without reading the entire methods section.

Common structural errors by section

In practice, the most frequent structural failure in an Introduction is excessive scope: a review of the entire relevant literature rather than a focused case for why this specific study, with this specific question, was necessary. In the Methods, the most common failure is an omission discovered only during peer review or attempted replication, namely a detail assumed to be “obvious” that a reader outside the research team needs in order to reconstruct the study; this is precisely the gap that reporting checklists such as the 25-item CONSORT list are designed to close by specifying the methodological detail that must appear3. In the Results, the most common failure is premature interpretation, for example writing “there was a surprisingly strong effect” rather than reporting the effect size and leaving interpretation to the Discussion. In the Discussion, the most common failure is the converse: the introduction of a new statistic or finding never reported in the Results, which undermines the structural expectation that a reader checking numbers will find them in one predictable location. A useful check against this failure is to read the Discussion specifically for any number that does not already appear, exactly, in the Results section; any such number is either a transcription error or an indication that a result was not reported where it belongs. The same check in the reverse direction, confirming that every number reported in the Results is addressed in the Discussion, is a useful secondary check for findings that were reported but never interpreted.

Evidence from a fifty-year survey on the long-standing dominance of IMRaD

The prevalence of IMRaD is sometimes assumed to result from recent journal policy, but a direct historical survey shows that the structure has been the dominant norm in biomedical publishing for decades rather than a recent standardization. Sollaci and Pereira's fifty-year survey of articles in major biomedical journals found that use of the IMRaD format rose sharply across the mid-twentieth century and had become the overwhelmingly dominant structure well before most current reporting guidelines, including CONSORT and PRISMA, were first published, indicating that those guidelines formalized and extended an established norm rather than creating it9. Day and Gastel's long-established guide to scientific writing, now in its eighth edition, traces the same pattern in disciplines beyond biomedicine, noting that journals in fields as varied as chemistry, agriculture and engineering converged independently on IMRaD or close variants over a similar period; the authors attribute this to the structure addressing a general problem, namely the organization of a report of empirical work for a reader who needs to locate specific kinds of information quickly, rather than to the outward spread of any single discipline's editorial preference7. This history has practical significance: a researcher who departs from IMRaD without a specific reason sanctioned by the journal is working against decades of accumulated reader expectation about where particular kinds of information will appear, not merely against the house style of one journal.

Key points

Key points

IMRaD is not a formatting convention but a structure built around the way readers use a paper, which is why major reporting guidelines assign specific checklist items to specific sections. The most common writing failures are structural rather than grammatical, consisting of content that belongs in one section appearing in another.

Practical application

Practical application

  1. The Introduction should establish the rationale for the specific study rather than serve as a literature review. It should conclude with a clear statement of the research question or hypothesis rather than a summary of everything known about the broader topic.
  2. The Methods section should be checked against the checklist of the relevant reporting guideline. For a trial, systematic review or observational study, the specific checklist of CONSORT, PRISMA or STROBE should be used to confirm that no required methodological detail is missing.
  3. Interpretation should be excluded from the Results, and new findings from the Discussion. Both sections should be read specifically for misplaced content, such as an interpretive phrase in the Results or a statistic reported for the first time in the Discussion.

Frequently asked questions

Most biomedical and many scientific journals use IMRaD or a close variant, although some fields and article types, for example narrative reviews or case reports, use different structures suited to their content. The instructions for authors of the target journal should always be consulted.

Because the purpose of each guideline is to ensure that specific, verifiable information is reported where a reader would expect to find it; assigning checklist items to sections, rather than leaving placement open, is what makes the guideline usable as a checklist during both writing and peer review.

Migration of content between sections: most often, interpretive language appearing in the Results before any formal discussion of meaning, and methodological detail assumed to be obvious and omitted from the Methods entirely, only to emerge later as a reviewer query.

Yes, for many study types. The CONSORT extension for abstracts, developed by Hopewell and colleagues, requires trial abstracts to report items such as the design, the result for the primary outcome with a confidence interval and the trial registration number, since abstracts are read far more often than full papers and are prone to inconsistency with the body text.

Sollaci and Pereira's fifty-year survey found that IMRaD became the dominant structure across major biomedical journals well before most current reporting guidelines were first published; CONSORT, PRISMA and STROBE therefore formalized an established structural norm rather than creating a new one.

References

  1. EQUATOR Network. Reporting Guidelines for Health Research. read 10 October 2026. View the EQUATOR Network Library
  2. International Committee of Medical Journal Editors. Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals: Preparing a Manuscript. read 10 October 2026. View ICMJE Manuscript Preparation Recommendations
  3. Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332. read 10 October 2026. View on BMJ
  4. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, for the STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-1457. read 10 October 2026. View on The Lancet
  5. Hopewell S, Clarke M, Moher D, et al, for the CONSORT Group. CONSORT for reporting randomised trials in journal and conference abstracts. Lancet. 2008;371(9609):281-283. read 10 October 2026. View on The Lancet
  6. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. read 10 October 2026. View on BMJ
  7. Day RA, Gastel B. How to Write and Publish a Scientific Paper. 8th ed. Cambridge University Press; 2016. read 10 October 2026. View publisher page
  8. American Medical Association. AMA Manual of Style: A Guide for Authors and Editors. 11th ed. Oxford University Press. read 10 October 2026. View AMA Manual of Style
  9. Sollaci LB, Pereira MG. The introduction, methods, results, and discussion (IMRAD) structure: a fifty-year survey. Journal of the Medical Library Association. 2004;92(3):364-367. read 10 October 2026. View on Journal of the Medical Library Association
  10. Council of Science Editors. Scientific Style and Format: The CSE Manual for Authors, Editors, and Publishers. read 10 October 2026. View Scientific Style and Format

Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.

How to cite this article

Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.

Pubrica Academy. (2026, October 10). Research Writing: Structuring a Manuscript with IMRaD and Reporting Guidelines. Pubrica. https://pubrica.com/academy/study-guide/research-writing/

This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.

IMRaD Section Responsibility Checklist

For use in checking that content is placed in the section responsible for it.

[ ] Introduction ends with a clear research question or hypothesis, not a general literature survey
[ ] Methods includes enough detail for an outside team to reconstruct the study
[ ] Methods checked against the relevant reporting guideline (CONSORT/PRISMA/STROBE) checklist
[ ] Results reports findings without interpretive language
[ ] Discussion introduces no new statistics or findings not already reported in Results
[ ] Discussion explicitly addresses limitations and relates findings to existing literature

Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.

How Pubrica can help

Pubrica’s manuscript structuring service checks draft papers section by section against the functions of the IMRaD sections and the relevant reporting guideline, identifying content that belongs in a different section before submission.

Find something else

Search the Pubrica Academy

Access is free and requires no account. Enter a topic, or open the full library to filter by category, sub-topic or resource type.

Placement of manuscript content in the expected section

A scoping assessment is free and takes two business days. It provides a written assessment of what the work requires and which specialist would undertake it.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.